Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care: Merger Effective Nov 01, 2026; Record Date Nov 18, 2026
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 20 Oct 2026, 07:12 PM IST · BSE ID: 630a89eb-6f78-4d03-86f4-d89a5344c3da
View Original BSE Filing (PDF)
💡
In Simple Terms
A merger between Dr. Agarwals Health Care and Dr. Agarwals Eye Hospital is effective November 01, 2026, with a record date of November 18, 2026.
🤖 AI Summary
- Board approved Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited.
- The Scheme of Amalgamation becomes effective on November 01, 2026, with April 01, 2026, as the Appointed Date.
- The authorized share capital of Dr. Agarwals Health Care Limited will increase from INR 90,00,00,000 to INR 110,00,00,000.
- Wednesday, November 18, 2026, is fixed as the Record Date for allotting consideration shares.
- Share exchange ratio is 23 Equity Shares of ₹1 each of Transferee for every 2 Equity Shares of ₹10 each of Transferor.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Authorized Share Capital (Pre-Scheme)
INR 90,00,00,000
Authorized Share Capital (Post-Scheme)
INR 110,00,00,000
🏢 How This Affects the Company
The amalgamation integrates Dr. Agarwals Eye Hospital Limited into Dr. Agarwals Health Care Limited, potentially consolidating operations and market presence.
The authorized share capital of Dr. Agarwals Health Care Limited will increase by INR 20,00,00,000, impacting the capital structure post-merger.
The merger streamlines two entities under a single corporate structure, potentially leading to operational synergies and integrated management.
👥 What This Means For Shareholders
✅
Action Required
Eligible shareholders of Dr. Agarwals Eye Hospital Limited must ensure their shares are held in dematerialized form by the record date.
👤
Who Is Affected
Shareholders of Dr. Agarwals Eye Hospital Limited will receive 23 fully paid-up Equity Shares of ₹1 each of Dr. Agarwals Health Care Limited for every 2 Equity Shares of ₹10 each held.
🔍
Management Signal
The decision demonstrates management's commitment to completing the approved corporate restructuring and integrating entities as planned.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Monitor share allotment to Dr. Agarwals Eye Hospital shareholders post November 18, 2026.
Observe future filings for consolidated financial results from the combined entity.
Review any disclosures regarding operational synergies post-merger effectiveness.
LOW RISK
The filing confirms the completion of a corporate action previously approved by the NCLT, reducing uncertainty.
💡 Investor Takeaway
Dr. Agarwals Health Care Limited's merger with Dr. Agarwals Eye Hospital Limited is effective November 01, 2026, with a record date of November 18, 2026, for consideration shares. The authorized share capital will increase from INR 90,00,00,000 to INR 110,00,00,000.
⚖️ Strengths & Concerns
✅ Positives
- Completion of the NCLT-sanctioned Scheme of Amalgamation provides clarity on the corporate structure and integration timeline.
- Increased authorized share capital from INR 90,00,00,000 to INR 110,00,00,000 provides capacity for future equity issuance.
📅 Company Track Record
Previous filings indicated NCLT approval for the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited, with shareholder meetings set for July 02, 2026. This filing confirms the effectiveness and record date following NCLT sanction.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When does the Scheme of Amalgamation for Dr. Agarwals Health Care become effective?
The Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited becomes effective on November 01, 2026.
What is the record date for allotting consideration shares in the Dr. Agarwals Health Care merger?
The Record Date for determining eligible equity shareholders of Dr. Agarwals Eye Hospital Limited to receive consideration shares is Wednesday, November 18, 2026.
How does the merger affect the authorized share capital of Dr. Agarwals Health Care Limited?
The authorized share capital of Dr. Agarwals Health Care Limited will increase from INR 90,00,00,000 prior to effectiveness to INR 110,00,00,000 post effectiveness of the Scheme.
What is the share exchange ratio for the Dr. Agarwals Health Care amalgamation?
The share exchange ratio is 23 fully paid-up Equity Shares of face value of ₹1 each of Dr. Agarwals Health Care Limited for every 2 fully paid-up Equity Shares of face value of ₹10 each held in Dr. Agarwals Eye Hospital Limited.
Questions based on this BSE filing only. For information purposes.